Science Explorer Interactive view Map
Company · Utrecht · Netherlands

Genmab (Netherlands)

genmab.comROR OpenAlex
World rank, all time
#12,324
of 42,892
Rank in Netherlands
#151
of 464
Research works
209
▼ 7% vs 2013–17
Citations
8.7k
41.7 per fractional work
Top-10% rate
14.4%
record average 16.5%
Open access
43%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.02× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.39× its world share, 10 worksBiochemistry, Geneti…Immunology and Microbiology: 22.08× its world share, 13 worksImmunology and Micro…Neuroscience: 0.18× its world share, 0 worksNeuroscienceChemistry: 1.03× its world share, 1 worksChemistryComputer Science: 0.06× its world share, 0 worksComputer ScienceEngineering: 0.33× its world share, 3 worksEngineeringEnvironmental Science: 0.12× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.25× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.13× its world share, 0 worksPhysics and AstronomyMedicine: 2.61× its world share, 28 worksMedicineVeterinary: 0.70× its world share, 0 worksVeterinaryDecision Sciences: 0.24× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.02× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 22.1×. Every wedge is a field page.

Who are the top researchers at Genmab (Netherlands)?

Ranked on the composite score, Paul W.H.I. Parren, Wim K. Bleeker and David Satijn lead among researchers whose main affiliation is Genmab (Netherlands).

  1. 1 Paul W.H.I. Parren Netherlands · #207,046 worldwide 227 citations · 46 works
  2. 2 Wim K. Bleeker Netherlands · #381,152 worldwide 102 citations · 19 works
  3. 3 David Satijn Netherlands · #1,210,382 worldwide 39 citations · 16 works
  4. 4 Esther C.W. Breij Netherlands · #1,295,193 worldwide 19 citations · 24 works
  5. 5 Erik H. Rozemuller Netherlands · #1,568,943 worldwide 1 citations · 27 works
All ranked researchers at Genmab (Netherlands)

Which keywords describe research at Genmab (Netherlands)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Cancer Immunotherapy, Antibody Engineering, Fc Receptors, Immunotherapy and Autoimmunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation8▲ 129×2 topics
  2. Monoclonal Antibodies8▲ 153×3 topics
  3. Therapeutic Antibodies7▲ 183×2 topics
  4. Cancer Immunotherapy7▲ 80×3 topics
  5. Antibody Engineering7▲ 218×1 topic
  6. Fc Receptors7▲ 218×1 topic
  7. Immunotherapy5▲ 12×6 topics
  8. Autoimmunity4▲ 56×2 topics
  9. Foxp34▲ 227×1 topic
  10. Lymphoma4▲ 48×2 topics
  11. TGF-ß4▲ 50×1 topic
  12. Tumor Microenvironment4▲ 17×6 topics
  13. Tumor Regression4▲ 64×2 topics
  14. Innate Immunity4▲ 22×3 topics
  15. CAR T Cells4▲ 84×1 topic
  16. Chimeric Antigen Receptor4▲ 84×1 topic
  17. Immunity4▲ 15×3 topics
  18. Antigen Presentation3▲ 63×2 topics
  19. Dendritic Cells3▲ 61×1 topic
  20. Immune Checkpoint Blockade3▲ 50×1 topic
  21. PD-1 and PD-L13▲ 50×1 topic
  22. Tumor Antigen3▲ 89×1 topic
  23. Cancer3▲ 3.9×9 topics
  24. NK Cell Recognition3▲ 68×1 topic
  25. Natural Killer Cells3▲ 68×1 topic
  26. Gene Expression2▲ 6.2×6 topics
  27. Biosensors2▲ 6.1×3 topics
  28. Vaccine Development2▲ 12×2 topics
  29. Chemotherapy2▲ 4.2×7 topics
  30. Cytomegalovirus2▲ 98×1 topic
  31. Infection2▲ 12×1 topic
  32. PET Imaging2▲ 16×3 topics
  33. Rituximab2▲ 18×2 topics
  34. Glycans1▲ 76×1 topic
  35. Immune System1▲ 10×1 topic
  36. Targeted Therapy1▲ 11×4 topics
  37. Biopharmaceuticals1▲ 38×3 topics
  38. Breast Cancer1▲ 8.5×1 topic
  39. DNA nanotechnology1▲ 15×1 topic
  40. HER21▲ 71×1 topic

Which research topics does Genmab (Netherlands) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, CAR-T cell therapy research and Cancer Immunotherapy and Biomarkers.

Monoclonal and Polyclona…7Monoclonal and Polyclonal Antibodies Research: 7 fractional worksT-cell and B-cell Immunology: 4 fractional worksCAR-T cell therapy research: 4 fractional worksCancer Immunotherapy and Biomarkers: 3 fractional worksImmunotherapy and Immune Responses: 3 fractional worksImmune Cell Function and…3Immune Cell Function and Interaction: 3 fractional worksCytomegalovirus and herpesvirus research: 2 fractional worksGlycosylation and Glycoproteins Research: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksAdvanced biosensing and bioanalysis techniques: 1 fractional works
Radiology, Nuclear Medicine and ImagingImmunologyOncologyEpidemiology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 7 works
  2. 2 T-cell and B-cell Immunology Immunology 4 works
  3. 3 CAR-T cell therapy research Oncology 4 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 3 works
  5. 5 Immunotherapy and Immune Responses Immunology 3 works
  6. 6 Immune Cell Function and Interaction Immunology 3 works
  7. 7 Cytomegalovirus and herpesvirus research Epidemiology 2 works
  8. 8 Glycosylation and Glycoproteins Research Molecular Biology 1 works
  9. 9 HER2/EGFR in Cancer Research Oncology 1 works
  10. 10 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.9%not open57.1%

World: 28% of research is openly available.

with international co-authors50.3%domestic only49.7%

World: 19% is written across borders.

How has Genmab (Netherlands)'s research output changed?

Output in 2018–2022 was 7% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Utrecht

All research institutions in Utrecht

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.